REGENTIDE NMN Trademark

Trademark Overview


On Wednesday, May 19, 2021, a trademark application was filed for REGENTIDE NMN with the United States Patent and Trademark Office. The USPTO has given the REGENTIDE NMN trademark a serial number of 90722587. The federal status of this trademark filing is REGISTERED as of Tuesday, October 17, 2023. This trademark is owned by Jiangsu Chengxin Pharmaceutical Co., Ltd.. The REGENTIDE NMN trademark is filed in the Pharmaceutical Products category with the following description:

Dietary and nutritional supplements containing nicotinamide mononucleotides
regentide nmn

General Information


Serial Number90722587
Word MarkREGENTIDE NMN
Filing DateWednesday, May 19, 2021
Status700 - REGISTERED
Status DateTuesday, October 17, 2023
Registration Number7191772
Registration DateTuesday, October 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements


Goods and ServicesDietary and nutritional supplements containing nicotinamide mononucleotides
Disclaimer with Predetermined Text"NMN"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJiangsu Chengxin Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressNantong, Jiangsu 226200
CN

Party NameJiangsu Chengxin Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressNantong, Jiangsu 226200
CN

Party NameJiangsu Chengxin Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNantong, Jiangsu 226200
CN

Trademark Events


Event DateEvent Description
Tuesday, October 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 17, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 22, 2023CASE RETURNED TO EXAMINATION
Thursday, June 22, 2023NOTICE OF ALLOWANCE CANCELLED
Thursday, June 22, 2023PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, June 20, 2023ASSIGNED TO PETITION STAFF
Tuesday, June 6, 2023TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, May 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 5, 2023SOU EXTENSION 2 GRANTED
Friday, May 5, 2023SOU EXTENSION 2 FILED
Friday, May 5, 2023SOU TEAS EXTENSION RECEIVED
Friday, October 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 12, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 12, 2022SOU EXTENSION 1 FILED
Wednesday, October 12, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 10, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 7, 2022EXAMINER'S AMENDMENT ENTERED
Monday, February 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 7, 2022EXAMINERS AMENDMENT E-MAILED
Monday, February 7, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, January 28, 2022ASSIGNED TO EXAMINER
Tuesday, August 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED